NEWS: Infermedica named to the 2022 CB Insights’ Digital Health 150 List
Diamond illustration

Category: Product updates

Symptom Checker 3—what’s new?
Photo of Aleksandra JędruchŁukasz Przywarty
Multiple authors

Symptom Checker 3—what’s new?

We've introduced a new version of Symptom Checker along with improvements to ensure the best healthcare for people worldwide.

Pediatrics enriches our medical content

Infermedica expands platform with pediatric assessment tools

We’ve expanded our medical knowledge base with hundreds of medical concepts dedicated to the pediatric population.

New feature: Specialist Recommender

Specialist Recommender is now available

Meet our new tool that adds recommendations of the physician and communication channel, to our pre-diagnosis processes.

COVID-19 Risk Assessment tool is here

COVID-19 Risk Assessment tool is here

As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.

Infermedica 2019: Year in Review

Infermedica 2019: Year in Review

2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.

COVID-19 is a global emergency requiring the entire world community’s focus and commitment to contain and eventually lessen its impact on public health and economies.

COVID-19 and Infermedica

COVID-19 is a global emergency requiring the entire world community’s focus and commitment to contain and eventually lessen its impact on public health and economies.

Infermedica 2018: Year in Review

Infermedica 2018: Year in Review

With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.

We’ve moved Symptomate to the next level

We’ve moved Symptomate to the next level

Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.

Infermedica 2017: Year in review

Infermedica 2017: Year in review

Over three million diagnostic interviews conducted with patients. Amongst other changes at Infermedica in 2017.